8-K filed May 16, 2024, 7:59 PM ET ticker DRS CIK 0001833756

other material confidence high sentiment neutral materiality 0.45

Leonardo DRS stockholders approve ESPP (2M shares) and amended equity plan at annual meeting

Leonardo DRS, Inc.

ESPP authorized up to 2M shares; purchase price 90% of FMV on purchase date; payroll deductions up to 10% of compensation.
Amended 2022 Omnibus Equity Compensation Plan approved; allows various equity awards for employees, directors, consultants.
All 9 director nominees elected with >236M votes each; advisory say-on-pay passed with 250.5M for vs 0.8M against.
Ratification of Ernst & Young as independent auditor for FY2024 approved with 255.2M votes for.
ESPP and amended plan effective May 15, 2024; no material financial terms changed beyond share reserve.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-24-023788
form_type: 8-K
ticker: DRS
cik: 0001833756
company_name: Leonardo DRS, Inc.
filed_at: 2024-05-16T23:59:59+00:00
discovered_at: 2026-05-14T18:03:20.571521+00:00
generated_at: 2026-06-01T21:40:00.376966+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-24-023788
json_url: https://secwatch.observer/filing/0001628280-24-023788.json
markdown_url: https://secwatch.observer/filing/0001628280-24-023788.md
text_url: https://secwatch.observer/filing/0001628280-24-023788.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/drs-20240515.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

2753bb5f43221f2f6410db5e6097498dd4615b7b

Leonardo DRS, Inc. shareholders approved Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan at the 2024-05-15 meeting.

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

5fe34aa82860c547160cd94527695171c4e4ea89

Leonardo DRS, Inc. shareholders approved Approval of the Amendment and Restatement of the Leonardo DRS, Inc. 2022 Omnibus Equity Compensation Plan at the 2024-05-15 meeting.

Approval of the Amendment and Restatement of the Leonardo DRS, Inc. 2022 Omnibus Equity Compensation Plan 250,467,618 861,989 87,959 3,912,857

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7d4d81cb1dc209168270050168a3a1034075eeba

Leonardo DRS, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024 at the 2024-05-15 meeting.

Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024 255,204,772 67,207 58,444 N/A

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

b3411a48762a7f152d53f9d1c014443561195a1b

Leonardo DRS, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

Election of Directors Shares Voted For Shares Voted Against Withheld Broker Non-Votes William J. Lynn III 249,843,624 N/A 1,573,942 3,912,857 Frances F. Townsend 249,969,986 N/A 1,447,580 3,912,857 Gail S. Baker 250,761,350 N/A 656,216 3,912,857 Dr. Louis R. Brothers 250,768,672 N/A 648,894 3,912,857 David W. Carey 249,336,972 N/A 2,080,594 3,912,857 General George W. Casey, Jr. 250,763,399 N/A 654,167 3,912,857 Mary E. Gallagher 250,765,518 N/A 652,048 3,912,857 Kenneth J. Krieg 236,280,607 N/A 15,136,959 3,912,857 Eric Salzman 250,051,465 N/A 1,366,101 3,912,857

SEC 8-K Item 5.07 confidence 0.85 SEC evidence

cdd6949fb1262b6f2988d0b70a6cab6ab8c5a1ef

Leonardo DRS, Inc. shareholders approved Advisory Resolution Regarding Compensation of the Company’s NEOs at the 2024-05-15 meeting.

Advisory Resolution Regarding Compensation of the Company’s NEOs 250,541,067 755,296 121,203 3,912,857

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

Comparable filings

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

Advisory vote to approve the fiscal 2026 compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 493,864,228 117,716,717 668,510 102,463,325

Filing page SEC filing

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

PROPOSAL 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for calendar year 2026. Votes For Votes Against Abstentions 134,853,955 7,100,190 646,621

Filing page SEC filing

SIRI

Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors

SIRIUS XM HOLDINGS INC. June 1, 2026, 4:28 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

Item 2 – Advisory Vote on Named Executive Officer Compensation The holders of our common stock approved, on a non-binding advisory basis, the compensation paid to our named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 228,280,853 4,764,836 1,349,137 51,448,019

Filing page SEC filing

ESPR

Esperion shareholders approve 7M-share increase to 2022 equity incentive plan

Esperion Therapeutics, Inc. June 1, 2026, 4:22 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 167,083,447 8,765,273 1,360,136 —

Filing page SEC filing

LUV

Southwest shareholders approve amended equity plan with 4.75M share increase; all directors elected

SOUTHWEST AIRLINES CO May 20, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

3. Proposal 3 – Approval of the Southwest Airlines Co. Amended and Restated 2007 Equity Incentive Plan: VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 408,346,613 28,870,401 1,635,532 90,613,942

Filing page SEC filing

Regulus Therapeutics Inc.

Regulus shareholders approve 2019 Equity Plan amendment adding 9.5M shares

Regulus Therapeutics Inc. May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

Proposal 5. The Company’s stockholders approved the Amended 2019 Plan which, among other things, increased the number of shares of our common stock authorized for issuance under the 2019 Plan by 9,500,000 shares and modified the calculation of the annual automatic share reserve increase to take into account shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. Votes For Votes Against Abstentions Broker Non-Votes 32,563,555 5,916,084 29,301 3,688,130

Filing page SEC filing

OSUR

OraSure shareholders approve 3M share increase in stock plan, charter amendment limiting officer liability

ORASURE TECHNOLOGIES INC May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

ITEM 1 . Election of two Class III Directors for Terms Ending in 2027. NAME Votes For Votes Against Abstentions Broker Non-Votes Nancy J. Gagliano, M.D. 57,243,711 4,832,639 46,575 5,007,157 Lelio Marmora 57,332,773 4,732,865 57,287 5,007,157

Filing page SEC filing

Nemaura Medical Inc.

Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150

Nemaura Medical Inc. May 17, 2024, 7:59 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857

Comparable filing

On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the “Company”) approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the “Articles”) to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) ranging in ratio between 1-for-10 and 1-for-150, with one share of Common Stock being issued for a range of between each 10 and 150 shares of Common Stock issued and outstanding, with such final ratio to be determined by the Board following approval thereof by the shareholders of the Company, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock (the “Reverse Split”), and to amend the Articles to effect the Reverse Split.

Filing page SEC filing

Source: SEC EDGAR

accession 0001628280-24-023788

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.